{"id":"NCT03436199","sponsor":"Adamas Pharmaceuticals, Inc.","briefTitle":"Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment","officialTitle":"A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-03-29","primaryCompletion":"2019-12-10","completion":"2019-12-10","firstPosted":"2018-02-19","resultsPosted":"2021-12-21","lastUpdate":"2021-12-21"},"enrollment":558,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Walking Impairment","Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"ADS-5102, 137 mg","otherNames":["ADS-5102","amantadine extended release"]},{"type":"DRUG","name":"ADS-5102, 274 mg","otherNames":["ADS-5102","amantadine extended release"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"ADS-5102, 137 mg","type":"EXPERIMENTAL"},{"label":"ADS-5102, 274 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"OTHER"}],"summary":"This study assessed the efficacy and safety of ADS-5102 (at daily doses of 137 mg or 274 mg) compared with placebo in MS patients with walking impairment.","primaryOutcome":{"measure":"Timed 25 Foot Walk (T25FW, Feet/Second): the Proportion of Subjects With a â‰¥ 20% Increase in Walking Speed (Measured by T25FW) From Baseline at Week 16 (Responder Analysis)","timeFrame":"16 weeks","effectByArm":[{"arm":"ADS-5102 137 mg","deltaMin":0.176,"sd":null},{"arm":"ADS-5102 274 mg","deltaMin":0.211,"sd":null},{"arm":"Placebo","deltaMin":0.113,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0811"},{"comp":"OG001 vs OG002","p":"0.0104"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":12},"locations":{"siteCount":84,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":187},"commonTop":["Urinary tract infection","Oedema peripheral","Fall","Dry mouth","Constipation"]}}